Your browser doesn't support javascript.
loading
High-intensity local treatment of clinical node-positive urothelial carcinoma of the bladder alongside systemic chemotherapy improves overall survival.
Sood, Akshay; Keeley, Jacob; Palma-Zamora, Isaac; Novara, Giacomo; Elshaikh, Mohamed; Jeong, Wooju; Hensley, Patrick; Navai, Neema; Peabody, James O; Trinh, Quoc-Dien; Rogers, Craig G; Menon, Mani; Abdollah, Firas.
Afiliação
  • Sood A; VCORE - Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, Michigan; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electroni
  • Keeley J; VCORE - Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, Michigan.
  • Palma-Zamora I; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
  • Novara G; Department of Surgery, Oncology and Gastroenterology-Urology, University Hospital of Padova, Padova, Italy.
  • Elshaikh M; Department of Radiation Oncology, Henry Ford Hospital, Detroit, Michigan.
  • Jeong W; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
  • Hensley P; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Navai N; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Peabody JO; VCORE - Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, Michigan; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
  • Trinh QD; Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusettsa.
  • Rogers CG; VCORE - Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, Michigan; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
  • Menon M; VCORE - Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, Michigan; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
  • Abdollah F; VCORE - Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, Michigan; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Urol Oncol ; 40(2): 62.e1-62.e11, 2022 02.
Article em En | MEDLINE | ID: mdl-34348860
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2022 Tipo de documento: Article